Feldt-Rasmussen B, Mathiesen E R, Hegedüs L, Deckert T
N Engl J Med. 1986 Mar 13;314(11):665-70. doi: 10.1056/NEJM198603133141101.
Thirty-six patients with insulin-dependent diabetes mellitus who had Albustix-negative urine but elevated urinary albumin excretion (30 to 300 mg per 24 hours) were matched in pairs according to their urinary albumin level, blood glycosylated hemoglobin level, and sex and assigned randomly to either unchanged conventional treatment or continuous insulin infusion. During the next 12 months a significant improvement in glycemic control was observed in the insulin-infusion group, with a reduction in the mean glycosylated hemoglobin level from 9.5 to 7.3 percent. There was no change in the control group (9.3 to 9.2 percent). No significant change in albumin excretion was observed in either group. The mean blood pressure increased slightly in both groups (from 98 to 101 mm Hg in the insulin-infusion group and from 98 to 103 mm Hg in the control group). Kidney size was significantly reduced in all patients during insulin infusion, but no consistent change was observed in the control group. No significant change was observed in the glomerular filtration rate. Our data suggest that the pathologic processes causing microalbuminuria in early renal disease are not reversed during 12 months of strict metabolic control.
36例胰岛素依赖型糖尿病患者,尿蛋白定性试验(Albustix)结果为阴性,但尿白蛋白排泄率升高(每24小时30至300毫克),根据尿白蛋白水平、糖化血红蛋白水平和性别进行配对,然后随机分为常规治疗不变组或持续胰岛素输注组。在接下来的12个月中,胰岛素输注组的血糖控制有显著改善,平均糖化血红蛋白水平从9.5%降至7.3%。对照组无变化(9.3%至9.2%)。两组的白蛋白排泄均无显著变化。两组的平均血压均略有升高(胰岛素输注组从98毫米汞柱升至101毫米汞柱,对照组从98毫米汞柱升至103毫米汞柱)。胰岛素输注期间,所有患者的肾脏大小均显著减小,但对照组未观察到一致变化。肾小球滤过率无显著变化。我们的数据表明,在严格的代谢控制12个月期间,早期肾脏疾病中导致微量白蛋白尿的病理过程并未逆转。